SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 12.50
+1.75 (16.28%)
At close: Mar 6, 2026
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 32.40 million as of March 6, 2026. Its market cap has decreased by -30.45% in one year.
Market Cap
32.40M
Enterprise Value
28.61M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.50
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 32.40M, an increase of 105.97%. That is a compound annual growth rate of 8.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 27.18M |
| Poolbeg Pharma | 29.61M |
| Aptamer Group | 24.27M |
| ImmuPharma | 35.89M |
| Sareum Holdings | 21.40M |
| Fusion Antibodies | 17.50M |
| Ondine Biomedical | 53.25M |
| hVIVO | 57.15M |